PTPRT and non-small cell lung carcinoma: In a recent investigation, the authors used mass spectrometry, Western blot, immunofluorescent staining, and next-generation sequencing (NGS) to investigate the response of PTPRT-deficient non-small-cell lung cancer to anti-PD-1therapy [81].